Tumor organoid screenings for biological characterizations and functional precision medicine
We develop strategies to test drugs in 3D tumor organoid models in a fast, reliable, high-throughput, inexpensive manner. Requiring few tumor cells, we aim to extend our methods to test combination of chemotherapies or targeted therapies directly on primary tumors from patients' biopsies or surgical samples in order to personalize treatment. Our most current work is focused on sarcoma, ovarian cancer, neuroendocrine tumors as well as neurofibromas.